Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,425-2,436 of 4,306
Drug study icon
TerminatedNCT01943019

Linagliptin in Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

In Bandar Tun Razak
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Malaysia
Sponsor
Monash University
Condition
Schizophrenia
Drug study icon
CompletedNCT02203838

Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Indivior Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00216671

Long-acting Injectable Risperidone in people with Schizophrenia After an Acute Episode

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Copenhagen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
Schizophrenia
Drug study icon
TerminatedNCT01834638

Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)

This study was terminated in the United States, in the United Kingdom, and in Russia. It focuses on schizophrenia.

Multiple locations, including Chino
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 66 Years
Countries
United States, United Kingdom, Russia
Sponsor
AbbVie
Condition
Schizophrenia
Drug study icon
CompletedNCT01104792

Long-term Study of Cariprazine in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Colombia, India, ...
Sponsor
Forest Laboratories
Condition
Schizophrenia
Drug study icon
CompletedNCT00790192

Lurasidone HCL - A 6-week Phase 3 Study of people with Acute Schizophrenia.

This study is completed in the United States, in India, in Romania, .... It focuses on schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States, India, Romania, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00789698

Lurasidone HCl - A Long Term Phase 3 Study of people with Chronic Schizophrenia

This study is completed in the United States, in Colombia, in India, .... It focuses on schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States, Colombia, India, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.